The featured sessions available for CME are as follows:

The Neurology of COVID-19 from Emerging Neurological Infections

• Approaches to Diagnosis and Developing Therapies
• Clinical Features and Lessons from Animal Models
• Epidemiology of the COVID19 Pandemic

Twitter and Social Media: A Role for Neurology and Neuroscience Engagement

• Effective Use of Twitter for Academic Scientists
• Evolving Visual Abstract: Equity in Imagery and Going Live
• eProfessionalism: Ethical and Responsible Use of Social Media

American Board of Psychiatry and Neurology (ABPN) Maintenance of Certification (MOC) Program: Lifelong Learning for Neurologists

• MOC/CC and Article Based Learning

Biomarker in Clinical Studies

• Biomarkers in ALS Trials
• Informative Predictive and Prognostic Biomarkers for Neuromuscular Clinical Trials
• Statistical Issues in Biomarker Research

Teleneurology in Academic Practice - Current State and Future Directions

• Future of Teleneurology in Academics
• Incorporation of Telestroke in the Residency Learning Environment
• Teleneurology in Academics: The Nuts and Bolts

The Gene Therapy Toolbox: AAV

• Introduction to AAV as a Delivery Vehicle for Gene Therapy in Neurology
• Lessons from Completed Ongoing AAV Gene Therapy Studies in Parkinson's Disease
• Therapeutic Approaches using AAV: Gene Transfer, Silencing and Editing

What Type Of Evidence Should Drive Clinical Decision-Making?

• Can Observational Studies Ever Support Strong Guideline Recommendations?
• Can the Endpoints Measured in Clinical Trials Capture Clinical Meaningfulness?
• Statistical Approaches to the Analysis of Data and limitations
• When RCTs and Real World Evidence Disagree: What Do We Believe?

The 2020 NINDS Strategic Plan: A Progress Report and Request for Input

• Opportunities within the NINDS Intramural Program
• Planning Strategically: Ushering Neuroscience Into the Future